Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of axitinib plus cisplatin/gemcitabine in squamous non-small cell lung cancer
2008-001726-13Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of axitinib in Pulmonary squamous cell carcinoma, sponsored by Pfizer. Primary endpoint: Overall confirmed objective response rate. Started Sep 2008; status: completed.
02
Drugs
axitinib
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on 2008-001726-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001726-13.